Viking Global Investors reduced stake in Adaptive Biotechnologies Corpor

This post was originally published on this site

Viking Global Investors’s holding in Adaptive Biotechnologies Corpor decreased to about 30 million shares with the transaction.

Viking Global Investors first bought Adaptive Biotechnologies Corpor stock in the second quarter of 2019. Viking Global Investors also owns Boston Scientific Corporation (NYSE:BSX), Zimmer Biomet Holdings Inc (NYSE:ZBH), Align Technology Inc (NASDAQ:ALGN) and Avantor, Inc. (NYSE:AVTR). Adaptive Biotechnologies Corpor is its number one position by number of shares and market value among health care supplies stocks.

Other investors who also reduced their Adaptive Biotechnologies Corpor shares include Gilder Gagnon Howe & Co., TimesSquare Capital Management, and Victory Capital Management. Contrary to Viking Global Investors, California State Teachers Retirement System, the T. Rowe Price Equity Income Fund, and Nikko Asset Management Americas added to ADPT shares, while Eminence Capital and BT Investment Management established new holdings in Adaptive Biotechnologies Corpor.